Literature DB >> 17824342

Minimally invasive surgery in total knee arthroplasty: the learning curve.

James H Lubowitz1, Amit Sahasrabudhe, David Appleby.   

Abstract

The purpose of this study is to quantitate the number of surgeries require to become proficient in minimally invasive surgery total knee arthroplasty (TKA). Operative duration is recorded for the first 100 patients having minimally invasive TKA by a single surgeon (J.H.L.). Learning is graphically represented by plotting time by patient number, generating logarithmic and linear curves that represent the rate of decrease in time (learning). The operative duration of the first block of 10 patients was significantly longer than that of the remaining 9 blocks. The learning curve for minimally invasive TKA approximates 10 patients, and decreases as surgical experience is gained.

Entities:  

Mesh:

Year:  2007        PMID: 17824342

Source DB:  PubMed          Journal:  Orthopedics        ISSN: 0147-7447            Impact factor:   1.390


  4 in total

1.  Introducing a knee endoprosthesis model increases risk of early revision surgery.

Authors:  Mikko Peltola; Antti Malmivaara; Mika Paavola
Journal:  Clin Orthop Relat Res       Date:  2011-12-09       Impact factor: 4.176

Review 2.  Does minimally invasive surgery improve short-term recovery in total knee arthroplasty?

Authors:  Tao Cheng; Tao Liu; Guoyou Zhang; Xiaochun Peng; Xianlong Zhang
Journal:  Clin Orthop Relat Res       Date:  2010-03-13       Impact factor: 4.176

3.  Minimal incision surgery as a risk factor for early failure of total hip arthroplasty.

Authors:  Bradley P Graw; Steven T Woolson; Heather G Huddleston; Stuart B Goodman; James I Huddleston
Journal:  Clin Orthop Relat Res       Date:  2010-09       Impact factor: 4.176

4.  Clinical outcomes and patient satisfaction after total knee arthroplasty: a follow-up of the first 50 cases by a single surgeon.

Authors:  Jacob A West; Travis Scudday; Scott Anderson; Nirav H Amin
Journal:  J Int Med Res       Date:  2019-03-12       Impact factor: 1.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.